Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 February 2021 Photo UFS photo archive
The National Control Laboratory for Biological Products (NCL) Building.

There can be no compromise when it comes to the quality of medicines made available to the public.

The UFS-based National Control Laboratory for Biological Products (NCL) is a full member of the international WHO-National Control Laboratory Network for Biologicals and one of 12 laboratories worldwide contracted to perform vaccine testing for the World Health Organisation (WHO). The NCL is also the only vaccine-testing laboratory in the country that performs the final quality-control testing of all human vaccine batches marketed in South Africa on behalf of the South African Health Products Regulatory Authority (SAHPRA).

In its role as a vaccine-testing laboratory for the WHO, the NCL helps to ensure that the vaccines purchased through the WHO prequalification programme for international distribution to resource-limited countries, meet the high standards of quality, safety, and efficiency. 

International testing standards

The laboratory received the status of a pharmaceutical testing laboratory after the South African Accreditation System (SANAS) endorsed its quality-management systems as of a high standard according to the International Standards Organisation’s requirements.

With its international testing standards, the NCL must ensure that all its operations – from the way documents are compiled and stored, to the maintenance of equipment and infrastructure, as well as staff competency – are performed according to international guidelines.

The laboratory has all the quality systems in place to ensure high-quality test results. The certificate of Good Manufacturing Compliance received in 2019 indicates that laboratory testing is on the expected level for any pharmaceutical testing laboratory and manufacturer. This certification is very strict and means that the NCL complies with exceptionally strict standards for pharmaceutical labs anywhere in the world. The certification offers the South African Health Products Regulatory Authority, the WHO, and other national control laboratories around the world the confidence that the test results from the NCL can be trusted.

Licensed as pharmaceutical manufacturer

The laboratory is also licensed as a pharmaceutical manufacturer. Although the lab does not manufacture, it needs to comply with manufacturing standards. It is rare for a pharmaceutical testing laboratory (such as the NCL) outside of a manufacturing context to qualify for both certifications.

News Archive

Good practice discussed during workshop of the ACU Benchmarking Programme
2012-09-10

 From the left are: Prof. John Brennan, assessor from the Open University in the UK; Prof. Driekie Hay, Vice-Rector: Academic, UFS; Mr Cliff Wragg, ACU Benchmarking Programme Manager; Prof. Ellen Hazelkorn, assessor from Dublin Institute of Technology in Ireland; and Mr Mike Gallagher, Executive Director of Go8 in Australia.
Photo: Johan Roux
10 September 2012

The ACU University Management Benchmarking Programme presented a workshop on the Bloemfontein Campus of the University of the Free State (UFS) from 27 to 29 August 2012.

The programme offers a unique and cost-effective opportunity for participating universities to compare their key management processes with those in a range of other universities. This helps to identify areas for change and assists in setting targets for improvement and identifying techniques for managing change. The outcomes of the programme provide models of good practice. It creates the opportunity for networking and a workshop, guided by internationally acknowledged subject experts. This year representatives from universities in among others Australia, the South Pacific, Canada, the United Kingdom (UK) and South Africa attended the workshop. The topics discussed were financial management, managing league tables and ranking and managing graduate outcomes.
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept